InvestorsHub Logo
icon url

Number sleven

04/28/23 5:07 PM

#407842 RE: ggwpq #407840

ggwpq, Insurance companies have no interest in paying a fair cost for anything.
Sleven,
icon url

Whalatane

04/28/23 5:10 PM

#407843 RE: ggwpq #407840

gg. Tirzepatide is one of several GLP-1 agonist drugs .

Diabetes drugs in the GLP-1 agonists class are generally taken by a shot (injection) given daily or weekly and include:

Dulaglutide (Trulicity) (weekly)
Exenatide extended release (Bydureon bcise) (weekly)
Exenatide (Byetta) (twice daily)
Semaglutide (Ozempic) (weekly)
Liraglutide (Victoza, Saxenda) (daily)
Lixisenatide (Adlyxin) (daily)
Semaglutide (Rybelsus) (taken by mouth once daily)


Tirzepatide, a dual GIP/GLP-1 receptor co-agonist for the treatment of type 2 diabetes with unmatched effectiveness regrading glycemic control and body weight reduction.



The MOA of GLP- 1 agonist drugs is well established .....multiple independent trials conform its effectiveness.
The indépendant confirming trials for the R-IT CV risk reduction ?

Kiwi